Dr. Nadine Stokar gained her veterinary degree at the University of Zürich, Switzerland in 2009. She performed her doctoral thesis at the Institute of Veterinary Pathology in Zürich in Prof. Pospischil/Borels group and did her residency in Anatomic Pathology at the Institute of Animal Pathology in Bern, Switzerland with Prof. Maja Suter and Prof. Horst Posthaus. After that, she was an instructor in Diagnostic Pathology in Bern and later on moved to the EPFL (Life Science School at the Swiss Polytechnical University of Lausanne, Switzerland) as a research pathologist supporting basic research with mice models for human diseases. Dr. Stokar joined Roche as a Toxicologic Pathologist in 2017 and holds currently the scientific area lead for Investigative Pathology. She is involved in discovery and regulatory drug development projects (Oncology and Neurodegeneration). Her expertise includes phenotyping of genetically engineered animal models and in vitro models for human diseases as alternative models in preclinical drug development. In the Pathology 2.0 initiative, she co-leads the ESTP&STP working group / SIG “Complex in vitro models & Pathology” with Dr. Lindsay Tomlinson (Pfizer) / Stephen Laing (Genentech).